Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-20
DOI
10.3389/fcvm.2021.642181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular complications in COVID-19
- (2020) Brit Long et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling
- (2020) Zena Wehbe et al. Frontiers in Pharmacology
- Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
- (2020) Luis F. García Frontiers in Immunology
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
- (2020) Kemmian D. Johnson et al. Frontiers in Medicine
- Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors
- (2020) Jalal Taneera et al. Biology-Basel
- Bilirubin in metabolic syndrome and associated inflammatory diseases: New perspectives
- (2020) Petr Novák et al. LIFE SCIENCES
- The Inflammasome in Times of COVID-19
- (2020) Juan Carlos de Rivero Vaccari et al. Frontiers in Immunology
- The Anti-Inflammatory Role of Bilirubin on “Two-Hit” Sepsis Animal Model
- (2020) Duc Tin Tran et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bilirubin alleviates alum–induced peritonitis through inactivation of NLRP3 inflammasome
- (2019) Yanke Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Bilirubin, a Cardiometabolic Signaling Molecule
- (2018) Terry D. Hinds et al. HYPERTENSION
- Gilbert Syndrome with Concomitant Hereditary Spherocytosis Presenting with Moderate Unconjugated Hyperbilirubinemia
- (2017) Mitsuhiko Aiso et al. INTERNAL MEDICINE
- Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1: A Summary of the Literature
- (2017) Vincent H. Ha et al. PHARMACOTHERAPY
- Hyperbilirubinemia, Augmentation of Endothelial Function, and Decrease in Oxidative Stress in Gilbert Syndrome
- (2012) Tatsuya Maruhashi et al. CIRCULATION
- Bilirubin: An Endogenous Molecule with Antiviral Activity in vitro
- (2012) Rosaria Santangelo et al. Frontiers in Pharmacology
- Eponym
- (2011) Andrew Fretzayas et al. EUROPEAN JOURNAL OF PEDIATRICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started